Are there safer, cheaper, natural alternatives to boost GLP-1 with diet and lifestyle? In this primer, Dr
Availability may be limited by local commissioning decisions and supply constraints, and some patients may need private prescription
Novo Nordisk files for FDA approval for CagriSema, the first once-weekly combination of GLP1 and amylin analogues owenhaskins Dec 19, 2025 2 min read Novo Nordisk has submitted a New Drug Application (NDA) to the FDA for once-weekly CagriSema (cagrilintide 2.4 mg and semaglutide 2.4 mg) injection, to be used with a reduced-calorie diet and increased physical activity, to reduce excess body weight and maintain weight reduction long term in adults with obesity or overweight in the presence of at least one weight-related comorbid condition
As research continues to evolve, GLP-1 medications may become an integral part of more personalized and effective weight management strategies
Post-ischemic leakiness of the blood-brain barrier: a quantitative and systematic assessment by Patlak plots